S Arends

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. pmc The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
    S Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, P O Box 30001, 9700 RB Groningen, The Netherlands
    Osteoporos Int 22:1431-9. 2011
  2. ncbi request reprint The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis
    S Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands
    Clin Exp Rheumatol 28:661-8. 2010
  3. doi request reprint Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
    P M Meiners
    Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Ann Rheum Dis 71:1297-302. 2012

Collaborators

Detail Information

Publications3

  1. pmc The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
    S Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, P O Box 30001, 9700 RB Groningen, The Netherlands
    Osteoporos Int 22:1431-9. 2011
    ....
  2. ncbi request reprint The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis
    S Arends
    Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands
    Clin Exp Rheumatol 28:661-8. 2010
    ....
  3. doi request reprint Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
    P M Meiners
    Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Ann Rheum Dis 71:1297-302. 2012
    ..To evaluate the responsiveness of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) and EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) in patients with primary Sjögren's syndrome (pSS) treated with rituximab...